Why Telix Pharmaceuticals shares are up 80% over the past year

Tom Richardson | August 1, 2019

Telix Pharmaceuticals is an oncology researcher with a renal cancer treatment at the Phase III stage. More »

Biotech speccy Paradigm is being tipped for the big time

Tom Richardson | July 31, 2019

Paradigm (ASX: PAR) has $78 million cash on hand and a goal to commercialise osteoarthritis drugs. More »

3 small cap ASX healthcare shares which could have big futures

James Mickleboro | July 25, 2019

Telix Pharmaceuticals Ltd (ASX:TLX) shares are one of three to watch at the small end of the healthcare sector... More »

ASX small caps outperform on the Aussie dollar strength and rate cut bets

Brendon Lau | July 19, 2019

ASX shares at the smaller end of the market are outperforming along with the Australian dollar as the global investors up their bets that... More »

Why the Telix Pharmaceuticals share price slumped on Wednesday

Kenneth Hall | July 18, 2019

The Telix Pharmaceuticals Ltd (ASX: TLX) share price closed 4.2% lower on the ASX yesterday as the Aussie pharmaceuticals group completed a $40 million... More »

Telix Pharmaceuticals just boasted it’s one step closer to getting a cancer treatment approved

Tom Richardson | July 15, 2019

Telix Pharmaceuticals Ltd (ASX:TLX) could hand investors huge gains or losses. More »

3 ASX small cap healthcare shares which could have big futures

James Mickleboro | July 11, 2019

Could these small cap healthcare shares provide stronger returns than Cochlear Limited (ASX:COH) and CSL Limited (ASX:CSL) over the next decade? More »

3 exciting small cap ASX healthcare shares to watch in FY20

James Mickleboro | July 8, 2019

Volpara Health Technologies Ltd (ASX:VHT) shares are one of three at the small end of the healthcare sector that could be worth watching... More »

Why Appen and these ASX shares just stormed to 52-week highs or better

James Mickleboro | July 3, 2019

The Appen Ltd (ASX:APX) share price is one of three charging to a 52-week high or better on Wednesday. Here's why... More »

The Telix share price climbs 14% as it boasts of multi billion dollar market opportunity

Motley Fool Staff | June 19, 2019

Telix Pharmaceuticals Ltd (ASX: TLX) is a speculative cancer research business. More »

Why I would buy ResMed and these ASX healthcare shares

James Mickleboro | April 24, 2019

Why I would buy ResMed Inc (ASX:RMD) and two other ASX healthcare shares this month... More »

Why the AVITA Medical share price crashed 29% lower today

James Mickleboro | April 10, 2019

The AVITA Medical Ltd (ASX:AVH) share price has crashed lower on Wednesday. Is this why? More »

3 exciting small cap ASX healthcare shares to watch

James Mickleboro | March 12, 2019

Nanosonics Ltd (ASX:NAN) shares are one of three at the small end of the market that I would buy this month... More »

Why the Bionomics share price rocketed 75% higher today

James Mickleboro | February 18, 2019

The Bionomics Ltd (ASX:BNO) share price has rocketed 75% higher on Monday. Here's why... More »